Financials, Healthcare Dec 30, 2021 06:49 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 30 - Fangsheng pharmaceutical announced that it plans to increase the capital and shares of Ruixin pharmaceutical, a wholly-owned subsidiary of the company, together with Kangrui venture fund and some small and medium-sized chain pharmacies in China (no more than 196, hereinafter referred to as "business alliance"), of which the company subscribed 51 million yuan and Kangrui venture fund 54.48 million yuan, The total subscribed capital contribution of the partnership established by the business alliance shall not exceed 54.52 million yuan. After the above capital increase, the company's direct shareholding in Ruixin pharmaceutical decreased from 100% to 39.44%, but it is still the controlling shareholder of Ruixin pharmaceutical.
Related companies: